Short communicationEmergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa
Section snippets
Acknowledgements
The authors thank Hoffmann-La Roche Ltd. (Basel, Switzerland), GSK (Melbourne, Australia) and BioCryst (Birmingham, AL, USA) for the provision of oseltamivir carboxylate, zanamivir, and peramivir, respectively. Pyrosequencing primer designs were kindly provided by Dr. Larisa Gubareva, CDC, USA. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing.
References (20)
- et al.
Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries
Antivir. Res.
(2008) - et al.
Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses
Antivir. Res.
(2009) - et al.
Influenza virus neuraminidase inhibitors
Lancet
(2000) - et al.
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
Antivir. Res.
(2004) - et al.
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
Antivir. Res.
(2002) - et al.
Resistant influenza A viruses in children treated with oseltamivir: descriptive study
Lancet
(2004) - Alexander, W.J., Harman, L.A., Collis, P.J., Elder, J., Kilpatrick, J.M., Atiee, G., Mead, E., 2007. Nasal and...
- et al.
Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa
Emerg. Infect. Dis.
(2008) PHYLIP-phylogeny inference package (version 3 2)
Cladistics
(1989)- et al.
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007–08
Emerg. Infect. Dis.
(2009)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 Elsevier B.V. All rights reserved.